pre-IPO PHARMA

COMPANY OVERVIEW

Currax Pharmaceuticals LLC is a specialty pharmaceutical business focused on acquiring and commercializing prescription drugs within the US market. Currax distributes a range of both branded and generic pharmaceutical products, including Silenor®, Treximet®, Zohydro® ER with BeadTek®, the authorized generic of Treximet®, and now CONTRAVE® and ONZETRA® Xsail®.


LOCATION

  • Morristown, NJ, USA

  • THERAPEUTIC AREAS

  • Pain

  • WEBSITE

    https://www.curraxpharma.com


    CAREER WEBSITE

    https://www.curraxpharma.com/careers/benefits/


    SOCIAL MEDIA


    INVESTORS



    PRESS RELEASES


    Aug 29, 2022

    One Size Does Not Fit All™: Currax Pharmaceuticals Launches New Campaign to Address Emotional Eating Challenges Faced by Individuals Seeking Weight Loss


    Jan 10, 2022

    Currax Pharmaceuticals Appoints Michael Kyle, M.D., as Senior Vice President, Chief Medical Officer


    Oct 26, 2021

    Currax Pharmaceuticals Announces the Appointment of Ed Cinca to Senior Vice President, Global Marketing and Strategic Alliance Management


    Oct 21, 2021

    Currax Pharmaceuticals Granted Type C Meeting with FDA Regarding its Phase 3 Study to Evaluate the Safety and Efficacy of CX-101


    Sep 30, 2021

    Currax Pharmaceuticals Hosted Ribbon-Cutting Ceremony to Mark the Opening of its Nashville Headquarters


    For More Press Releases


    Google Analytics Alternative